Wave Life Sciences (WVE) Financials

$4.91

$0.05 (1.03%)

As on 08-Sep-2026 16:09EDT

Market cap

$958 Mln

Revenue (TTM)

$65 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-187.49	-151.03	-19.43	-127.78	-88.99
Cash Flow from Investing Activities	--	-0.72	-0.94	-1.12	-1.26	-0.56
Cash from Financing Activities	--	488.24	253.89	132.53	67.19	55.83
Net Cash Inflow / Outflow	--	--	--	--	-61.85	-33.73

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.09	-1.13	-0.56	-0.52	-1.72	-2.14
Cash EPS ($)	--	-1.09	-0.51	-0.44	-1.61	-1.97
Adjusted Book Value ($)	--	2.92	1.22	0.36	--	0.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.04	-0.88	-0.18	-1.36	-1.56
Free Cash Flow per Share ($)	--	-1.04	-0.88	-0.19	-1.37	-1.57

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-52.48	-63.27	-178.97	-589.12	-134.06
ROE (%)	-41.33	-55.56	-77.87	2,106.32	2,570.05	-198.53
ROA (%)	-42.68	-41.26	-30.94	-27.30	-91.58	-50.28
EBIT Margin (%)	-316.11	-478.33	-89.57	-51.36	-4,459.30	-298.92
Net Margin (%)	-309.73	-478.33	-89.57	-50.76	-3,095.91	-268.49
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-30.42	-0.61	-0.04	30.05	-0.91	1.04
EBIT Growth (%)	-59.11	-110.68	-66.71	64.24	-32.89	20.16
Net Profit Growth (%)	-55.90	-110.68	-68.67	64.46	-32.38	18.45
EPS Growth (%)	-22.11	-1.01	-0.07	0.70	0.19	0.30
Book Value Growth (%)	164.24	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-14.98	-21.97	-9.63	-4.07	-1.47
Price / Book Value	2.12	5.82	10.17	13.97	-14.59	5.53
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-10.12	-12.67	-20.99	-7.87	-3.98	-0.52
Close Price ($)	5.81	17.00	12.37	5.05	7.00	3.14
High Price ($)	21.73	21.73	16.74	7.12	7.09	12.17
Low Price ($)	5.02	5.28	3.50	3.15	1.16	3.07
Market Cap ($ Cr)	957.65	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.12	0.81	-0.83	0.92
Short term debt to equity ratio	0.01	0.02	0.04	0.17	-0.12	0.15
Current Ratio	9.99	6.47	2.89	1.26	1.38	2.53
Quick Ratio	9.99	--	--	1.26	--	--
Interest Coverage	--	--	--	--	-103.12	-8.48

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	1.36	2.99	1.31	18.61	--	--
Asset Turnover	0.14	0.09	0.35	0.54	0.02	0.17
Receivable days	--	11.53	37.95	33.99	--	133.75
Inventory Days	--	--	0.00	0.00	--	31.27
Payable days	--	659.41	613.48	590.25	436.90	31.58
Cash Conversion Cycle	--	--	-575.52	-556.26	--	133.43

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.